This inventor holds 6 USPTO granted patents. Top assignees: Meiji Seika Kaisha, Ltd., Meiji Seika Kabushiki Kaisha. Active years: 1998-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa-ken, JP (1998)
- Yokohama, JP (2002 - 2006)
- Tokyo, JP (2008)
Company Filing History:
Years Active: 1998-2008
Title: Naoto Ohkura: Innovator in Pharmaceutical Chemistry
Introduction
Naoto Ohkura is a distinguished inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of six patents to his name, his work has had a profound impact on the treatment of various diseases.
Latest Patents
Ohkura's latest patents include innovative compounds such as azalide and azalactam derivatives. These compounds are effective in the prevention and treatment of infections caused by microbes. Another notable patent involves nitrogen-containing heterocyclic compounds and benzamide compounds, which exhibit triglyceride biosynthesis inhibitory activity in the liver. These compounds are particularly useful for treating hyperlipidemia and arteriosclerotic diseases, showcasing Ohkura's commitment to advancing medical science.
Career Highlights
Throughout his career, Naoto Ohkura has worked with reputable companies, including Meiji Seika Kaisha, Ltd. and Meiji Seika Kabushiki Kaisha. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in pharmaceutical development.
Collaborations
Ohkura has collaborated with notable colleagues such as Kiyoaki Katano and Yukiko Hiraiwa. These partnerships have fostered a collaborative environment that has led to innovative solutions in the field of pharmaceuticals.
Conclusion
Naoto Ohkura's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of effective treatments for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

